Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004744 · ClinicalTrials.gov registry record · NA
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01004744 is a NA study that has completed, run by Columbia University. The registered enrollment target is 10 participants.
The verdict
NCT01004744, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of a short term administration of a targeted therapy (i.e., anastrozole) in women with newly diagnosed early invasive or non invasive breast cancer during the interval between their breast biopsy and surgery. Anastrozole is a form of hormonal therapy which is part of the standard treatment for hormone sensitive breast cancer in postmenopausal women. This clinical model is being used to evaluate the biologic effects of this drug on a specific molecular pathway called the PI3K/AKT signaling pathway.
Interventions
- DRUG Anastrozole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01004744
The ClinicalTrials.gov registry entry for NCT01004744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anastrozole is the first listed.
NCT01004744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01004744 about?
NCT01004744 is a clinical study titled "Pre-Surgical Intervention for Targeted Therapies for Breast Cancer". The purpose of this study is to determine the feasibility of a short term administration of a targeted therapy (i.e., anastrozole) in women with newly diagnosed early invasive or non invasive breast cancer during the interval between their breast biopsy and surgery. Anastrozole is a form of hormonal...
What is the current status of trial NCT01004744?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2007-07. Estimated completion is 2009-08.
What interventions are being tested in trial NCT01004744?
The interventions under investigation include: Anastrozole (DRUG).
Who is sponsoring clinical trial NCT01004744?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.